GBM Lunch

Matthias Peipp: Novel Strategies in Improving Effector Cell Activation in Antibody-Based Immunotherapy

01.12.2021

Matthias Peipp

12:30-13:30

Speaker: Matthias Peipp, Research Head & Mildred Scheel Professor, Stem Cell Transplantation & Immunotherapy, University of Kiel

Chair: Stefan Zielonka, Protein Engineering & Antibody Technologies, Merck KGaA, Darmstadt

Organizers: Study Group Protein Engineering and Design

 

Zurück